Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:51 pm Sale | 2025-03-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Point72 Asset Management, L.P. | 1,543,931 2.300% | -1,681,319 (-52.13%) | Filing History |
| 2025-05-15 08:46 am Sale | 2025-03-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Deep Track Capital, LP | 3,442,833 5.040% | -557,167 (-13.93%) | Filing History |
| 2025-05-15 07:00 am Sale | 2025-03-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Bain Capital Life Sciences Opportunities IV, L.P. | 6,843,954 9.990% | -251,826 (-3.55%) | Filing History |
| 2025-05-13 7:29 pm Purchase | 2025-03-18 | 13D | Olema Pharmaceuticals, Inc. OLMA | Logos Global Management LP | 3,208,875 4.700% | 3,208,875 (New Position) | Filing History |
| 2025-04-15 5:04 pm Purchase | 2025-03-31 | 13G | Ivanhoe Electric Inc. IE | BlackRock Portfolio Management LLC | 7,849,151 5.900% | 7,849,151 (New Position) | Filing History |
| 2025-02-14 4:45 pm Purchase | 2024-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm BioCapital Advisors LP | 7,429,355 9.990% | 1,925,755 (+34.99%) | Filing History |
| 2025-01-13 4:24 pm Sale | 2025-01-08 | 13G | Olema Pharmaceuticals, Inc. OLMA | Bain Capital Life Sciences Opportunities IV, L.P. | 7,095,780 9.990% | -374,434 (-5.01%) | Filing History |
| 2024-12-11 4:30 pm Purchase | 2024-12-04 | 13G | Olema Pharmaceuticals, Inc. OLMA | Bain Capital Life Sciences Opportunities IV, L.P. | 7,470,214 9.990% | 7,470,214 (New Position) | Filing History |
| 2024-12-04 7:49 pm Sale | 2024-12-04 | 13D | Olema Pharmaceuticals, Inc. OLMA | BIOTECHNOLOGY VALUE FUND L P | 7,557,237 9.990% | -1,578,656 (-17.28%) | Filing History |
| 2024-11-14 4:34 pm Sale | 2024-09-30 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm BioCapital Advisors LP | 5,503,600 9.600% | -2,400,000 (-30.37%) | Filing History |
| 2024-11-14 09:20 am Purchase | 2024-09-30 | 13G | Olema Pharmaceuticals, Inc. OLMA | Deep Track Capital, LP | 4,000,000 6.980% | 959,752 (+31.57%) | Filing History |
| 2024-06-14 4:34 pm Purchase | 2024-06-04 | 13G | Olema Pharmaceuticals, Inc. OLMA | Point72 Asset Management, L.P. | 3,225,250 5.700% | 3,225,250 (New Position) | Filing History |
| 2024-06-06 6:49 pm Sale | 2024-06-04 | 13D | Olema Pharmaceuticals, Inc. OLMA | Logos Global Management LP | 3,248,818 5.800% | -1,018,130 (-23.86%) | Filing History |
| 2024-03-22 4:31 pm Purchase | 2024-03-14 | 13G | Olema Pharmaceuticals, Inc. OLMA | Deep Track Capital, LP | 3,040,248 5.440% | 3,040,248 (New Position) | Filing History |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm BioCapital Advisors LP | 7,903,600 14.300% | 100,000 (+1.28%) | Filing History |
| 2024-02-14 3:08 pm Purchase | 2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Cormorant Asset Management, LP | 2,456,800 4.490% | 374,800 (+18.00%) | Filing History |
| 2024-02-14 12:53 pm Sale | 2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Kynam Capital Management, LP | 0 0.000% | -2,025,234 (Position Closed) | Filing History |
| 2024-02-12 12:21 pm Sale | 2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | JANUS HENDERSON GROUP PLC JHG | 700,100 1.300% | -2,357,206 (-77.10%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | BlackRock Inc. BLK | 3,263,907 6.000% | 1,958,403 (+150.01%) | Filing History |
| 2023-11-27 5:39 pm Purchase | 2023-09-12 | 13D | Olema Pharmaceuticals, Inc. OLMA | Logos Global Management LP | 4,266,948 7.800% | 508,130 (+13.52%) | Filing History |